Skip to Content
You are currently on the new version of our website. Access the old version .
BioMedBioMed
  • Review
  • Open Access

16 November 2026

22 Pages

Ischaemic Stroke Keeps Time: A Critical Review of Circadian Biology from Thrombus Formation to Translational Failure

and
1
Department of Elderly Care and Stroke, Altnagelvin Area Hospital, Western Health and Social Care Trust, Glenshane Road, Londonderry BT47 6SB, UK
2
Department of Neurology, Kokilaben Dhirubhai Ambani Hospital, Rao Saheb Achutrao Patwardhan Marg, Four Bungalows, Andheri West, Mumbai 400053, Maharashtra, India
*
Author to whom correspondence should be addressed.
BioMed2026, 6(4), 24;https://doi.org/10.3390/biomed6040024 
(registering DOI)
This article belongs to the Special Issue Biomarker, Diagnostic and Therapeutic Advances in Cerebrovascular and Hemorrhagic Disorders

Abstract

Ischaemic stroke does not occur at random hours. Onset clusters in the morning, and several physiological correlates of that pattern are well described: an endogenous circadian peak in circulating plasminogen activator inhibitor-1, platelets that aggregate more readily in the hours after rising, and the morning surge in blood pressure. What remains unsettled is whether the hour of onset also influences how quickly brain tissue is lost and how well it responds to treatment. This critical narrative review draws together molecular, experimental and clinical evidence and organises it as a Three-Clock Model: a trigger clock that sets when vessels occlude, a tissue clock that governs the pace of infarct growth, and a treatment clock that modulates the response to reperfusion and to adjunctive or neuroprotective therapy. Human cohorts have reported larger ischaemic cores and faster infarct growth after night-time onset or during night-time interhospital transfer, the latter measured directly with serial diffusion-weighted imaging, and time-of-day differences in thrombectomy outcome, but these associations are vulnerable to confounding by uncertain onset times, out-of-hours care and the gap between clock time and internal circadian phase. In rodents, three neuroprotective strategies reduced infarction when given during the animals’ inactive phase but not during the active phase, a mismatch that may have contributed to failed translation; other experiments disagree about which phase is more damaging. Large pragmatic trials of bedtime antihypertensive dosing have been neutral. We propose a ten-item CHRONO-STROKE minimum reporting dataset, which is author-proposed and unvalidated and intended to supplement existing consensus data elements, a clock-time-stratified design for trials of adjunctive therapy, and five testable predictions, as a means of establishing whether circadian biology deserves a place in acute stroke decision-making.

Article Metrics

Citations

Article Access Statistics

Article metric data becomes available approximately 24 hours after publication online.